Patent published on February 29, 2024

Medibotics' Patent: Machine Learning Helps Medical Devices Adjust Inside the Body

Medibotics' Patent: Using Machine Learning to Optimize Medical Devices Inside the Body

In the field of human circulatory assistance, a significant challenge has arisen concerning the accurate adjustment and optimization of implanted medical devices. Specifically, cardiovascular issues often manifest in the extremities, such as the feet and hands, where biometric information is crucial for effective device calibration. Unfortunately, traditional implantable cardiac devices lack the necessary sensors to gather this vital data, resulting in an unmet clinical need.

Addressing this problem, Medibotics, a renowned medical technology company, has unveiled a groundbreaking patent that leverages the power of machine learning and artificial intelligence (AI) to control the operation of implanted medical devices based on biometric indicators. Patent US20240065550A1 outlines a method or system designed to revolutionize cardiovascular functioning assistance, offering seamless adjustment and optimization through the integration of external wearable gadgets.

One of the significant advantages of this inventive approach is the potential implementation of multiple individually-controlled implanted blood pumps distributed throughout the patient's body. By employing a sophisticated feedback loop, these pumps can be selectively adjusted based on multifaceted analysis of blood pressure values obtained from external wearable gadgets. This innovative design introduces substantial benefits, including augmented native blood circulation without replacing cardiac function entirely. Consequently, heart healing and eventual recovery of functionality are promoted, reducing the need for more drastic measures such as heart transplantation or invasive full-cardiac-function replacement devices.

The patent also introduces a novel method for measuring body oxygenation levels from various locations on the body, leveraging wearable sensors such as oxygen saturation sensors, SpO2 sensors, and pulse oximeters. This approach facilitates accurate monitoring of oxygenation in different body regions, ensuring optimal physiological performance and potentially mitigating risks associated with poor circulation and oxygenation. In particular, by detecting low oxygenation levels in specific areas, the implanted system can trigger increased blood flow to these regions, safeguarding against physiological dysfunction and potential limb loss.

As envisioned by the patent's potential implementation, the future promises a world where individuals suffering from chronic heart conditions experience enhanced tissue health, accelerated wound healing, and even the avoidance of amputation. Imagine a scenario where a person's implanted medical device is seamlessly adjusted and optimized based on intricate analysis of their unique biometric indicators, with the final goal of improving their overall well-being and quality of life.

While Medibotics' patent represents a significant leap forward in medical technology, it's important to note that its appearance on the market is not guaranteed. As with any patent, further research, development, and regulatory approval processes are necessary before it can become a tangible reality for patients. Nonetheless, the potential impact of this invention offers hope for advancements in the realm of cardiovascular assistance and improved patient outcomes.

In summary, Medibotics' patent introduces an innovative approach to medical device optimization by harnessing the power of machine learning and AI. By seamlessly adjusting implanted devices based on biometric indicators obtained from external wearable gadgets, Medibotics aims to revolutionize human circulatory assistance. Although the path to market integration remains uncertain, the potential benefits this technology presents for managing chronic heart conditions and preserving overall tissue health are considerable.

P.S. It is important to note that this article discusses a recently published patent by Medibotics. While the patent outlines a groundbreaking invention, the future availability and commercialization of the technology are uncertain. Extensive research, development, and regulatory processes will be required to determine its feasibility and viability.

Explore more